Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-039104
Filing Date
2010-02-25
Accepted
2010-02-24 17:33:36
Documents
10
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1363822
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION dex31.htm EX-3.1 10525
3 MANUFACTURING AND DISTRIBUTION AGREEMENT - SANQUIN BLOEDVOORIENING dex1063.htm EX-10.63 219041
4 DISTRIBUTION AND MANUFACTURING SERVICES AGREEMENT - AMERICAS AND ISRAEL dex1064.htm EX-10.64 270899
5 EXCLUSIVE LICENSE AGREEMENT - DALE N. GERDING, M.D. dex1065.htm EX-10.65 96640
6 SUBSIDIARIES OF THE COMPANY dex21.htm EX-21 3409
7 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRN dex23.htm EX-23 3406
8 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 9510
9 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 9515
10 SECTION 906 CERTIFICATION OF CEO AND CFO dex321.htm EX-32.1 5298
  Complete submission text file 0001193125-10-039104.txt   1993436
Mailing Address 397 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 397 EAGLEVIEW BLVD EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

EIN.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21699 | Film No.: 10630800
SIC: 2834 Pharmaceutical Preparations